Gilead Sciences Inc
(GILD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,936,000 | 5,412,000 | 4,699,000 | 4,739,000 | 4,296,000 |
| Marketable Securities | 936,000 | 973,000 | 961,000 | 924,000 | 1,029,000 |
| Receivables | 4,162,000 | 4,777,000 | 4,354,000 | 4,118,000 | 3,787,000 |
| Inventories | 1,576,000 | 1,507,000 | 1,463,000 | 1,494,000 | 1,482,000 |
| TOTAL | $13,456,000 | $14,443,000 | $13,554,000 | $13,175,000 | $12,629,000 |
| Non-Current Assets | |||||
| PPE Net | 5,479,000 | 5,475,000 | 5,349,000 | 5,299,000 | 5,253,000 |
| Investments And Advances | 1,327,000 | 1,245,000 | 1,282,000 | 1,337,000 | 1,427,000 |
| Intangibles | 36,662,000 | 37,208,000 | 37,754,000 | 38,199,000 | 38,645,000 |
| Other Non-Current Assets | 4,952,000 | 4,800,000 | 4,618,000 | 4,860,000 | 5,126,000 |
| TOTAL | $48,420,000 | $48,728,000 | $49,003,000 | $49,695,000 | $50,451,000 |
| Total Assets | $61,876,000 | $63,171,000 | $62,557,000 | $62,870,000 | $63,080,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,283,000 | 2,273,000 | 2,270,000 | 1,021,000 | 1,025,000 |
| Accounts payable and accrued liabilities | 627,000 | 905,000 | 614,000 | 565,000 | 583,000 |
| Accrued Expenses | 3,477,000 | 3,479,000 | 3,674,000 | 3,519,000 | 3,450,000 |
| Other current liabilities | 4,140,000 | 4,580,000 | N/A | N/A | N/A |
| TOTAL | $10,528,000 | $11,237,000 | $10,423,000 | $9,220,000 | $8,558,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,956,000 | 24,136,000 | 24,059,000 | 26,183,000 | 26,127,000 |
| Other Non-Current Liabilities | 5,078,000 | 3,923,000 | 3,985,000 | 3,897,000 | 4,800,000 |
| TOTAL | $30,409,000 | $30,725,000 | $31,077,000 | $33,435,000 | $34,607,000 |
| Total Liabilities | $40,937,000 | $41,962,000 | $41,500,000 | $42,655,000 | $43,165,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,247,353 | 1,247,105 | 1,254,244 | 1,253,367 | 1,254,313 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 15,223,000 | 15,687,000 | 15,756,000 | 15,117,000 | 14,986,000 |
| Other shareholders' equity | -78,000 | -29,000 | 74,000 | 66,000 | 61,000 |
| TOTAL | $20,939,000 | $21,209,000 | $21,057,000 | $20,215,000 | $19,915,000 |
| Total Liabilities And Equity | $61,876,000 | $63,171,000 | $62,557,000 | $62,870,000 | $63,080,000 |